Public limited company · Liège · incorporated on 03/11/2005 · 5,0 ETP
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,2 M € | +246.3% | 4,1 M € | +7.3% | 3,8 M € | +10.6% | 3,5 M € | +1554.0% | 209,2 k € | -96.3% | 5,6 M € | +56216.3% | 9,9 k € | -99.4% | 1,8 M € | +59.3% | 1,1 M € | -64.5% | 3,1 M € | +4298.2% | 70,8 k € | +258.1% | 19,8 k € | 0,0 € | -100.0% | 1,2 k € | 0,0 € | — | — | |||||
| Gross margin | — | — | — | — | — | — | — | — | -1,1 M € | -173.2% | 1,5 M € | +214.5% | -1,3 M € | -37.7% | -929,3 k € | -1629.0% | -53,7 k € | -820.0% | -5,8 k € | -25.3% | -4,7 k € | +20.0% | -5,8 k € | +82.6% | -33,5 k € | |||||||||
| EBITDA | -15,6 M € | +45.0% | -28,4 M € | -8.5% | -26,2 M € | -39.3% | -18,8 M € | -48260.4% | 39,0 k € | -99.4% | 6,2 M € | +214.7% | -5,4 M € | -428.9% | 1,6 M € | +228.1% | -1,3 M € | -198.7% | 1,3 M € | +191.5% | -1,4 M € | -45.1% | -978,7 k € | -1709.2% | -54,1 k € | -749.5% | -6,4 k € | -30.2% | -4,9 k € | +16.1% | -5,8 k € | +82.6% | -33,5 k € | |
| Operating profit | -20,4 M € | +34.0% | -31,0 M € | -3.1% | -30,0 M € | -21.0% | -24,8 M € | -870.8% | -2,6 M € | -203.0% | 2,5 M € | +145.5% | -5,5 M € | -435.0% | 1,6 M € | +226.1% | -1,3 M € | -199.9% | 1,3 M € | +190.9% | -1,4 M € | -44.1% | -986,7 k € | -1489.0% | -62,1 k € | -332.2% | -14,4 k € | -11.5% | -12,9 k € | +6.8% | -13,8 k € | +63.8% | -38,3 k € | |
| Profit/loss | -28,1 M € | +14.0% | -32,7 M € | -7.3% | -30,4 M € | -22.1% | -24,9 M € | -845.3% | -2,6 M € | -213.8% | 2,3 M € | +140.6% | -5,7 M € | -459.0% | 1,6 M € | +222.3% | -1,3 M € | -200.4% | 1,3 M € | +190.9% | -1,4 M € | -45.6% | -976,5 k € | -1564.6% | -58,7 k € | -309.1% | -14,3 k € | -3.6% | -13,8 k € | +0.5% | -13,9 k € | +63.7% | -38,3 k € | |
| Equity | 9,2 M € | +112.0% | -76,7 M € | -74.1% | -44,1 M € | -229.4% | -13,4 M € | -356.4% | 5,2 M € | -35.6% | 8,1 M € | +474.7% | -2,2 M € | -161.1% | 3,5 M € | +246202.3% | -1,4 k € | -100.1% | 1,3 M € | +230.2% | -996,1 k € | -408.9% | 322,5 k € | -72.2% | 1,2 M € | +7647.3% | -15,4 k € | -1386.6% | -1,0 k € | -108.1% | 12,8 k € | -52.1% | 26,7 k € | |
| Total assets | 36,6 M € | +1.5% | 36,1 M € | +17.0% | 30,8 M € | -2.8% | 31,7 M € | +41.9% | 22,3 M € | -27.5% | 30,8 M € | +34.5% | 22,9 M € | +2.9% | 22,3 M € | +1082.8% | 1,9 M € | +4.6% | 1,8 M € | -13.4% | 2,1 M € | +87.2% | 1,1 M € | -16.6% | 1,3 M € | +253.0% | 377,5 k € | +663.9% | 49,4 k € | -21.9% | 63,3 k € | +94.2% | 32,6 k € | |
| Cash | 18,5 k € | -99.4% | 3,0 M € | -11.2% | 3,4 M € | +194.2% | 1,2 M € | +152.8% | 456,1 k € | -77.9% | 2,1 M € | +2437.6% | 81,3 k € | -66.4% | 242,0 k € | -71.4% | 847,7 k € | +10.3% | 768,8 k € | +1.3% | 759,0 k € | +3854.5% | 19,2 k € | +43.7% | 13,4 k € | -47.9% | 25,6 k € | +3.9% | 24,7 k € | -18.9% | 30,4 k € | -5.0% | 32,0 k € | |
| Debts | 27,4 M € | -75.7% | 112,8 M € | +50.6% | 74,9 M € | +66.1% | 45,1 M € | +170.9% | 16,6 M € | -26.7% | 22,7 M € | -9.4% | 25,1 M € | +33.9% | 18,7 M € | +894.0% | 1,9 M € | +274.2% | 503,4 k € | -83.6% | 3,1 M € | +290.1% | 788,6 k € | +357.3% | 172,5 k € | -56.1% | 392,9 k € | +678.7% | 50,5 k € | 0.0% | 50,5 k € | +762.0% | 5,9 k € | |
| Staff | 5 | 5 | 8 | 7 | 2 | 1,9 | 1,8 | 1,9 | 2,6 | 2,5 | 2 | 1 | — | — | — | — | — | |||||||||||||||||
Company — Opening of bankruptcy.
Public limited company loss-making in the latest fiscal year. Cash position declining (-99.4%).
Solid counterparty for a standard engagement.
NOVALON is a Public limited company incorporated in 2005. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Liège. It employs on average 5,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette